Why did DuPont end its lobbying relationship with Cross Potomac Consulting?

DuPont Specialty Products USA LLC terminated its lobbying engagement with Cross Potomac Consulting LLC effective April 3, 2026, as a direct result of its major corporate restructuring—which included spinning off its Electronics & Industrial segment—and the consequent realignment of its federal policy priorities toward healthcare packaging, water filtration, and specialty industrial materials.

What new policy areas is DuPont focusing on in its updated lobbying strategy?

Following the termination of its lobbying engagement with Cross Potomac Consulting, DuPont has shifted its lobbying strategy away from past priorities like semiconductor policy and toward new concerns including PFAS regulation, chemical safety, trade, and water infrastructure.

DuPont Ends Lobbying with Cross Potomac

May 28, 2026

DuPont Specialty Products USA LLC terminated its lobbying engagement with Cross Potomac Consulting LLC following a corporate restructuring. The move shifts federal policy priorities toward healthcare packaging, water filtration, PFAS regulation, and chemical safety.

Legis1

2026-04-02

DuPont completes aramids divestiture

2026-04-08

DuPont de Nemours Inc. Stock Outperforms Competitors on Strong Trading Day

2026-04-09

DuPont Expands Water Solutions With Inge UF Integrated Pre-Filter Modules

2026-04-09

DuPont Expands FilmTec™ Fortilife™ Portfolio for Advanced ZLD/MLD and Resource Recovery Applications

2026-04-14

DuPont Launches AmberChrom XT SL Chromatography Resins